UNSPSC 51283718: Cefonicid monosodium

This classification denotes a cephalosporin antibiotic C18H17N6O8S3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QD9G66C5UF, chemically known as (6r,7r)-7-((r)-mandelamido)-8-oxo-3-(((1-(sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, s-sodium salt, but more generally known as cefonicid monosodium, which bears US NIH Compound Identifier 6336979. Most nations, for tariff and trade purposes, schedule cefonicid monosodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFONICID MONOSODIUM remains US FDA's Preferred Term for this commodity. Cefonicid monosodium bears US NLM identifiers UMLS ID CL386475 and NCI Concept Code C76170. SMILES: C1CCC(CC1)[C@H](C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4NNNN4CS(=O)(=O)[O-])C(=O)O)O.[NA+].

UNSPSC 51283718 Cefonicid monosodium is a Commodity code that does not reflect the actual scope of state and local procurement activity posted under this classification. The recent opportunities tagged to this code involve naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription program implementation—none of which involve cefonicid monosodium, an antibiotic compound. The mismatch between the code's nominal scope and the work actually being solicited suggests either tagging error in the underlying procurement system or use of the code as a broad catchall for pharmaceutical and medical supply procurement. The issuing bodies include county health departments, state agencies, municipalities, and regional cooperative purchasing alliances; Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) appear in recent postings.

Recent activity spans Florida, Texas, Minnesota, and Oregon through cooperative purchasing participation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products, posted January 20, 2026 with proposals due March 26, 2026, represents a large-scale state and local procurement vehicle requiring NDC-level product specification and wholesaler relationship management. The City of Tampa's IFB for medical and first aid supplies for the Tampa Fire Department Rescue Division, posted March 25, 2026 with a March 13, 2026 response deadline and an estimated contract value of $700,000, is designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida's IFB for naloxone and safe drug deactivation systems (1,900 units and 800 systems annually), posted June 30, 2026 with a July 26, 2023 response deadline, requires quarterly deliveries and was potentially funded through FEMA. The Texas Health and Human Services Commission's RFI for direct-to-manufacturer prescription programs, posted April 3, 2026, signals exploratory market research rather than immediate procurement intent. The mismatch between the assigned code and actual solicitation scope limits the predictive value of this code for future business development targeting under the cefonicid monosodium classification.